Corporate Europe Observatory – Study shows EU Glyphosate assessment based on flawed science

The glyphosate battle is back. A new scientific analysis finds that most of industry’s studies provided to EU authorities to prove glyphosate’s safety, did not meet basic international scientific standards as set by the OECD. This comes at a moment when the European Food Safety Authority (EFSA) is about to start its re-assessment of glyphosate, a key ingredient of the infamous weed killer Roundup.

Corporate Europe Observatory is a research and campaign group working to expose and challenge the privileged access and influence enjoyed by corporations and their lobby groups in EU policy making.

Cross-posted from Corporate Europe Observatory

RoundUp spray canister in front of EU Commission

In 2015, the WHO’s International Agency for Research on Cancer (IARC) concluded that glyphosate –- is probably carcinogenic to humans. Pesticides that can cause cancer must be banned, according to EU legislation.

However, in 2017, after two years of controversy and scandals, Monsanto’s glyphosate weed killer was granted a re-approval by the EU, albeit for the unusually short period of five years, instead of the normal fifteen year period.

In the US, in the meantime, landmark court cases were taken against Monsanto (based on the IARC’s opinion) by thousands of cancer victims, and Bayer (the new owner of Monsanto) was forced to pay billions of US dollars in damages. Evidence obtained during these court cases showed that Monsanto actively undermined the science regarding the harmful effects of glyphosate.

In December 2022, the EU permit for glyphosate will expire. A dossier was submitted in December 2019 by the Glyphosate Renewal Group, a consortium of 8 glyphosate manufacturers, led by Bayer, calling for the pesticide to be approved again.

This new scientific review puts once more a finger on a sore spot: that national regulators and EU authorities alike do not seem to scrutinize thoroughly when looking at the quality of industry’s own studies. At the same time, they dismissed almost all publicly peer reviewed scientific studies.

The new scientific analysis shows that out of 53 industry studies the glyphosate manufacturers had submitted in the previous glyphosate approval process, only two can be assessed as scientifically ‘reliable’, when using the applicable OECD Guidelines. Of the studies 34 are ‘not reliable’ and 17 only ‘partly reliable’.

Genotoxicity studies indicate the risk of cancer and reproductive damage posed by a chemical. Public authorities that were involved in the previous European authorisation procedure – BfR in Germany and the European Food Safety Authority (EFSA) – wrongfully accepted these industry studies as key-evidence of the absence of glyphosate genotoxicity.

A first screening of industry’s 2020 new glyphosate application dossier shows that 38 of the same genotoxicity studies on “pure” glyphosate have been submitted once more to the EU authorities by industry as valid or supplementary.    

CEO with other civil society organisations is calling on EU authorities to take into account these new – from an environmental and health point of view very worrying – findings in the new authorisation procedure.

You can find the scientific study here

You can find a Q&A on the study here

You can find a backgrounder on the glyphosate battle so far here

BRAVE NEW EUROPE is a not-for-profit educational platform for economics, politics, and climate change that brings authors at the cutting edge of progressive thought together with activists and others with articles like this. If you would like to support our work and want to see more writing free of state or corporate media bias and free of charge, please donate here.

Be the first to comment

Leave a Reply

Your email address will not be published.


*